1.
Evaluation the serum levels of T3, T4, TSH, Thyroglobulin and Galactin-3 in patients with benign and malignant thyroid tumors. Journal of Pharmaceutical Negative Results. 2022;13(3):559-571. doi:10.47750/pnr.2022.13.03.085